AGIO
Price
$24.56
Change
-$0.51 (-2.03%)
Updated
Sep 20, 6:59 PM EST
42 days until earnings call
ATRA
Price
$1.76
Change
+$0.18 (+11.39%)
Updated
Sep 20, 6:59 PM EST
47 days until earnings call

Compare trend and price AGIO vs ATRA

Header iconAGIO vs ATRA Comparison
Open Charts AGIO vs ATRABanner chart's image
Agios Pharmaceuticals
Price$24.56
Change-$0.51 (-2.03%)
Volume$131.54K
CapitalizationN/A
Atara Biotherapeutics
Price$1.76
Change+$0.18 (+11.39%)
Volume$2.15M
CapitalizationN/A
View a ticker or compare two or three
AGIO vs ATRA Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
AGIO vs. ATRA commentary
Sep 21, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a Hold and ATRA is a StrongBuy.

COMPARISON
Comparison
Sep 21, 2023
Stock price -- (AGIO: $24.56 vs. ATRA: $1.76)
Brand notoriety: AGIO and ATRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGIO: 68% vs. ATRA: 290%
Market capitalization -- AGIO: $1.42B vs. ATRA: $157.72M
AGIO [@Biotechnology] is valued at $1.42B. ATRA’s [@Biotechnology] market capitalization is $157.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $424.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 0 FA rating(s) are green whileATRA’s FA Score has 0 green FA rating(s).

  • AGIO’s FA Score: 0 green, 5 red.
  • ATRA’s FA Score: 0 green, 5 red.
According to our system of comparison, AGIO is a better buy in the long-term than ATRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 5 TA indicator(s) are bullish while ATRA’s TA Score has 6 bullish TA indicator(s).

  • AGIO’s TA Score: 5 bullish, 5 bearish.
  • ATRA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ATRA is a better buy in the short-term than AGIO.

Price Growth

AGIO (@Biotechnology) experienced а -9.86% price change this week, while ATRA (@Biotechnology) price change was +18.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.61%. For the same industry, the average monthly price growth was +23.29%, and the average quarterly price growth was +30.30%.

Reported Earning Dates

AGIO is expected to report earnings on Nov 02, 2023.

ATRA is expected to report earnings on Nov 07, 2023.

Industries' Descriptions

@Biotechnology (-1.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for AGIO with price predictions.
OPEN
A.I.dvisor published
a Summary for ATRA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
AGIO($1.42B) has a higher market cap than ATRA($158M). AGIO YTD gains are higher at: -12.536 vs. ATRA (-46.341). ATRA has higher annual earnings (EBITDA): -349.11M vs. AGIO (-367.18M). AGIO has more cash in the bank: 703M vs. ATRA (154M). ATRA has less debt than AGIO: ATRA (64.7M) vs AGIO (78.9M). AGIO has higher revenues than ATRA: AGIO (20.1M) vs ATRA (6.86M).
AGIOATRAAGIO / ATRA
Capitalization1.42B158M898%
EBITDA-367.18M-349.11M105%
Gain YTD-12.536-46.34127%
P/E RatioN/AN/A-
Revenue20.1M6.86M293%
Total Cash703M154M456%
Total Debt78.9M64.7M122%
FUNDAMENTALS RATINGS
AGIO vs ATRA: Fundamental Ratings
AGIO
ATRA
OUTLOOK RATING
1..100
669
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
79
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9499
PRICE GROWTH RATING
1..100
6157
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AGIO's Valuation (48) in the Biotechnology industry is in the same range as ATRA (79). This means that AGIO’s stock grew similarly to ATRA’s over the last 12 months.

AGIO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ATRA (100). This means that AGIO’s stock grew similarly to ATRA’s over the last 12 months.

AGIO's SMR Rating (94) in the Biotechnology industry is in the same range as ATRA (99). This means that AGIO’s stock grew similarly to ATRA’s over the last 12 months.

ATRA's Price Growth Rating (57) in the Biotechnology industry is in the same range as AGIO (61). This means that ATRA’s stock grew similarly to AGIO’s over the last 12 months.

ATRA's P/E Growth Rating (100) in the Biotechnology industry is in the same range as AGIO (100). This means that ATRA’s stock grew similarly to AGIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGIOATRA
RSI
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 9 days ago
73%
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
77%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 7 days ago
82%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SIIAX15.96N/A
N/A
AlphaCentric Strategic Income A
GGOIX17.04N/A
N/A
Goldman Sachs Mid Cap Growth Instl
IIGIX9.39N/A
N/A
Voya Multi-Manager International Eq I
RPMGX97.19-0.35
-0.36%
T. Rowe Price Mid-Cap Growth
GCECX14.30-0.11
-0.76%
AB Global Core Equity C

AGIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGIO has been loosely correlated with BEAM. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if AGIO jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGIO
1D Price
Change %
AGIO100%
-2.03%
BEAM - AGIO
60%
Loosely correlated
+2.98%
NTLA - AGIO
60%
Loosely correlated
-1.11%
RARE - AGIO
58%
Loosely correlated
-0.58%
EDIT - AGIO
58%
Loosely correlated
-0.50%
CRSP - AGIO
56%
Loosely correlated
-1.81%
More

ATRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRA has been loosely correlated with CHRS. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRA jumps, then CHRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRA
1D Price
Change %
ATRA100%
+11.39%
CHRS - ATRA
52%
Loosely correlated
-2.17%
EDIT - ATRA
52%
Loosely correlated
-0.50%
NTLA - ATRA
52%
Loosely correlated
-1.11%
BEAM - ATRA
51%
Loosely correlated
+2.98%
BLUE - ATRA
50%
Loosely correlated
-1.87%
More